{"transactions":[{"id":4640109,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-10-14T18:36:41.000Z","date":"2026-10-11","kind":"exercise","planned":false,"acquired":false,"shares":23191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MiNK Therapeutics, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On October 11, 2023 the reporting person was granted RSUs under the Company's 2021 Equity Incentive Plan, vesting in three substantially equal annual installments on each of the third, fourth and fifth anniversaries of the grant date. This award was previously reported as covering 695,750 RSUs but was adjusted to 69,573 RSUs to reflect the 1-for-10 reverse stock split (rounding) that occurred on January 28, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On October 11, 2023 the reporting person was granted RSUs under the Company's 2021 Equity Incentive Plan, vesting in three substantially equal annual installments on each of the third, fourth and fifth anniversaries of the grant date. This award was previously reported as covering 695,750 RSUs but was adjusted to 69,573 RSUs to reflect the 1-for-10 reverse stock split (rounding) that occurred on January 28, 2025."}],"balance_after":46382,"derivative":{"underlying":"Common Stock","underlying_shares":23191},"source":{"system":"sec-edgar","filing":"0001193125-26-421529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526421529/ownership.xml","form_type":"4"}},{"id":4640108,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-14T18:36:41.000Z","date":"2026-10-12","kind":"sale","planned":false,"acquired":false,"shares":6938,"price":10.56,"value":73265.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents sales of shares, as a consequence of the vesting of restricted stock units, solely to satisfy tax withholding obligations incurred upon vesting."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.33 to $10.61. The reporting person undertakes to provide to the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":74195,"source":{"system":"sec-edgar","filing":"0001193125-26-421529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526421529/ownership.xml","form_type":"4"}},{"id":4640107,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-14T18:36:41.000Z","date":"2026-10-11","kind":"exercise","planned":false,"acquired":true,"shares":23191,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MiNK Therapeutics, Inc. (the \"Company\")."}],"balance_after":81133,"source":{"system":"sec-edgar","filing":"0001193125-26-421529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526421529/ownership.xml","form_type":"4"}},{"id":63,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T15:10:49.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":1279,"price":10.95,"value":14005.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":23929,"source":{"system":"sec-edgar","filing":"0001193125-26-379575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526379575/ownership.xml","form_type":"4"}},{"id":50,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":59,"kind":"person","name":"Holcomb John Bradley","position":1,"cik":"0002092279","reported_name":"Holcomb John Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T14:21:50.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":1233,"price":10.95,"value":13501.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":4691,"source":{"system":"sec-edgar","filing":"0001193125-26-379524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2092279/000119312526379524/ownership.xml","form_type":"4"}},{"id":49,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T14:20:55.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":1485,"price":10.95,"value":16260.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":24404,"source":{"system":"sec-edgar","filing":"0001193125-26-379522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000119312526379522/ownership.xml","form_type":"4"}},{"id":48,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T14:19:10.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":1622,"price":10.95,"value":17760.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":23591,"source":{"system":"sec-edgar","filing":"0001193125-26-379518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526379518/ownership.xml","form_type":"4"}},{"id":42,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T14:16:55.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":1633,"price":10.95,"value":17881.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":54770,"source":{"system":"sec-edgar","filing":"0001193125-26-379513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526379513/ownership.xml","form_type":"4"}},{"id":747376,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:04:03.000Z","date":"2026-06-04","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":12.7995,"value":12799.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors."}],"balance_after":21969,"source":{"system":"sec-edgar","filing":"0001193125-26-260084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526260084/ownership.xml","form_type":"4"}},{"id":747375,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:04:03.000Z","date":"2026-06-04","kind":"sale","planned":false,"acquired":false,"shares":500,"price":12.6835,"value":6341.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors."}],"balance_after":22969,"source":{"system":"sec-edgar","filing":"0001193125-26-260084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526260084/ownership.xml","form_type":"4"}},{"id":753904,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":59,"kind":"person","name":"Holcomb John Bradley","position":1,"cik":"0002092279","reported_name":"Holcomb John Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:27.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":1091,"price":12.38,"value":13506.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":3458,"source":{"system":"sec-edgar","filing":"0001193125-26-253474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526253474/ownership.xml","form_type":"4"}},{"id":753903,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":59,"kind":"person","name":"Holcomb John Bradley","position":1,"cik":"0002092279","reported_name":"Holcomb John Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:27.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":1239,"price":10.9,"value":13505.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Due to an administrative error, the RSUs for Q1 2026 Board and committee compensation were not filed timely."}],"balance_after":2367,"source":{"system":"sec-edgar","filing":"0001193125-26-253474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526253474/ownership.xml","form_type":"4"}},{"id":753920,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:20.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":1434,"price":12.38,"value":17752.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":23469,"source":{"system":"sec-edgar","filing":"0001193125-26-253470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526253470/ownership.xml","form_type":"4"}},{"id":753919,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:20.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":1629,"price":10.9,"value":17756.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Due to an administrative error, the RSUs for Q1 2026 Board and committee compensation were not filed timely."}],"balance_after":22035,"source":{"system":"sec-edgar","filing":"0001193125-26-253470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526253470/ownership.xml","form_type":"4"}},{"id":754219,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:17.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":1444,"price":12.38,"value":17876.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":53137,"source":{"system":"sec-edgar","filing":"0001193125-26-253468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000119312526253468/ownership.xml","form_type":"4"}},{"id":754218,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:17.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":1640,"price":10.9,"value":17876.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Due to an administrative error, the RSUs for Q1 2026 Board and committee compensation were not filed timely."}],"balance_after":51693,"source":{"system":"sec-edgar","filing":"0001193125-26-253468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000119312526253468/ownership.xml","form_type":"4"}},{"id":755060,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:14.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":1313,"price":12.38,"value":16254.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":22919,"source":{"system":"sec-edgar","filing":"0001193125-26-253466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000119312526253466/ownership.xml","form_type":"4"}},{"id":755059,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:14.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":1491,"price":10.9,"value":16251.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Due to an administrative error, the RSUs for Q1 2026 Board and committee compensation were not filed timely."}],"balance_after":21606,"source":{"system":"sec-edgar","filing":"0001193125-26-253466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000119312526253466/ownership.xml","form_type":"4"}},{"id":754321,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:03.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":1131,"price":12.38,"value":14001.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":22650,"source":{"system":"sec-edgar","filing":"0001193125-26-253461","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000119312526253461/ownership.xml","form_type":"4"}},{"id":754320,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:03.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":1285,"price":10.9,"value":14006.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Due to an administrative error, the RSUs for Q1 2026 Board and committee compensation were not filed timely."}],"balance_after":21519,"source":{"system":"sec-edgar","filing":"0001193125-26-253461","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000119312526253461/ownership.xml","form_type":"4"}},{"id":796541,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":59,"kind":"person","name":"Holcomb John Bradley","position":1,"cik":"0002092279","reported_name":"Holcomb John Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-30T20:30:09.000Z","date":"2025-09-23","kind":"grant","planned":false,"acquired":true,"shares":4174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options were awarded in accordance with the MiNK Therapeutics Inc. 2021 Amended and Restated Equity Incentive Plan on September 23, 2025 and will vest in three equal annual installments on each of September 23, 2026, 2027 and 2028 (provided Dr. Holcomb maintains a service relationship with the company through each such vesting date)."}],"balance_after":4174,"derivative":{"exercise_price":14.92,"expiration_date":"2035-09-23","underlying":"Common Stock","underlying_shares":4174},"source":{"system":"sec-edgar","filing":"0001193125-26-197482","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526197482/ownership.xml","form_type":"4"}},{"id":847949,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T22:22:03.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":500,"price":15.3,"value":7650.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors."}],"balance_after":20406,"source":{"system":"sec-edgar","filing":"0001193125-26-102581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526102581/ownership.xml","form_type":"4"}},{"id":847948,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T22:22:03.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":500,"price":15.5652,"value":7782.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors."}],"balance_after":20906,"source":{"system":"sec-edgar","filing":"0001193125-26-102581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526102581/ownership.xml","form_type":"4"}},{"id":847947,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T22:22:03.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":300,"price":15.2822,"value":4584.66,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors."}],"balance_after":21406,"source":{"system":"sec-edgar","filing":"0001193125-26-102581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526102581/ownership.xml","form_type":"4"}},{"id":847946,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T22:22:03.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":200,"price":10.1725,"value":2034.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors."}],"balance_after":21706,"source":{"system":"sec-edgar","filing":"0001193125-26-102581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526102581/ownership.xml","form_type":"4"}},{"id":860449,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-04T21:45:03.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":10.8258,"value":1082.58,"ownership":{"direct":true},"balance_after":21906,"source":{"system":"sec-edgar","filing":"0001193125-26-091707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526091707/ownership.xml","form_type":"4"}},{"id":860448,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-04T21:45:03.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":400,"price":10.8583,"value":4343.32,"ownership":{"direct":true},"balance_after":22006,"source":{"system":"sec-edgar","filing":"0001193125-26-091707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526091707/ownership.xml","form_type":"4"}},{"id":939047,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-14T21:05:02.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":10024,"price":11.12,"value":111466.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld for payment of the withholding taxes in relation to the stock issued to the reporting person on January 2, 2026, as previously reported on the Form 4 filed on January 6, 2026 (the \"Original Form 4\"). The Original Form 4 did not include the shares withheld for payment of withholding taxes in Table I. This amendment is being filed to correct this error."}],"balance_after":57942,"source":{"system":"sec-edgar","filing":"0001193125-26-012914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000119312526012914/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-06"}},{"id":945622,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:27:03.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the date of grant, with the remainder vesting in eight equal quarterly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":11.12,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193125-26-004799","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000119312526004799/ownership.xml","form_type":"4"}},{"id":945621,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-06T22:27:03.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":31474,"price":11.12,"value":349990.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the executive's 2025 performance bonus award paid in MiNK Therapeutics, Inc. common stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 100% of the award released on February 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"$11.12 was the fair market value of MiNK Therapeutics, Inc. Common Stock on January 2, 2026, the stock issuance date."}],"balance_after":67966,"source":{"system":"sec-edgar","filing":"0001193125-26-004799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000119312526004799/ownership.xml","form_type":"4"}},{"id":945994,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:24:02.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests on February 2, 2026, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":5395,"derivative":{"exercise_price":11.12,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":5395},"source":{"system":"sec-edgar","filing":"0001193125-26-004786","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000119312526004786/ownership.xml","form_type":"4"}},{"id":945494,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:22:11.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests on February 2, 2026, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":5395,"derivative":{"exercise_price":11.12,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":5395},"source":{"system":"sec-edgar","filing":"0001193125-26-004779","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312526004779/ownership.xml","form_type":"4"}},{"id":945857,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:21:42.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests on February 2, 2026, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":5395,"derivative":{"exercise_price":11.12,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":5395},"source":{"system":"sec-edgar","filing":"0001193125-26-004776","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000119312526004776/ownership.xml","form_type":"4"}},{"id":946998,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:19:39.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests on February 2, 2026, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":5395,"derivative":{"exercise_price":11.12,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":5395},"source":{"system":"sec-edgar","filing":"0001193125-26-004769","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000119312526004769/ownership.xml","form_type":"4"}},{"id":981223,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T21:10:09.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":1612,"price":11.09,"value":17877.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":50053,"source":{"system":"sec-edgar","filing":"0001193125-25-306681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000119312525306681/ownership.xml","form_type":"4"}},{"id":981716,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T21:10:08.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":1466,"price":11.09,"value":16257.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":20115,"source":{"system":"sec-edgar","filing":"0001193125-25-306680","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000119312525306680/ownership.xml","form_type":"4"}},{"id":980924,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T21:10:07.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":1601,"price":11.09,"value":17755.09,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":22406,"source":{"system":"sec-edgar","filing":"0001193125-25-306678","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312525306678/ownership.xml","form_type":"4"}},{"id":980915,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":59,"kind":"person","name":"Holcomb John Bradley","position":1,"cik":"0002092279","reported_name":"Holcomb John Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T21:10:05.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":1128,"price":11.09,"value":12509.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":1128,"source":{"system":"sec-edgar","filing":"0001193125-25-306679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312525306679/ownership.xml","form_type":"4"}},{"id":981282,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T21:10:03.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":1263,"price":11.09,"value":14006.67,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":20234,"source":{"system":"sec-edgar","filing":"0001193125-25-306675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000119312525306675/ownership.xml","form_type":"4"}},{"id":981977,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T16:10:04.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":1218,"price":11.09,"value":13507.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":19126,"source":{"system":"sec-edgar","filing":"0001193125-25-306676","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000119312525306676/ownership.xml","form_type":"4"}},{"id":1023999,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-03T20:05:24.000Z","date":"2025-09-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":5351,"price":15.36,"value":82191.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld for payment of the withholding taxes in relation to the stock issued to reporting person on September 9, 2025, as previously reported on the Form 4 filed on September 11, 2025 (the \"Original Form 4\"). The Original Form 4 did not include the shares withheld for payment of withholding taxes in Table I. This amendment is being filed to correct this error."}],"balance_after":36492,"source":{"system":"sec-edgar","filing":"0001193125-25-230098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000119312525230098/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-11"}},{"id":1042525,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T20:46:24.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the date of grant, with the remainder vesting in eight equal quarterly installments thereafter, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":50000,"derivative":{"exercise_price":15.36,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193125-25-201376","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000119312525201376/ownership.xml","form_type":"4"}},{"id":1042524,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T20:46:24.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":18229,"price":15.36,"value":279997.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the executive's 2024 performance bonus award paid in MiNK Therapeutics, Inc. common stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 100% of the award released on October 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"$15.36 was the fair market value of MiNK Therapeutics, Inc. Common Stock on September 9, 2025, the stock issuance date."}],"balance_after":41913,"source":{"system":"sec-edgar","filing":"0001193125-25-201376","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000119312525201376/ownership.xml","form_type":"4"}},{"id":1042959,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T20:05:13.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":3225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":3225,"derivative":{"exercise_price":15.36,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":3225},"source":{"system":"sec-edgar","filing":"0001193125-25-201317","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000119312525201317/ownership.xml","form_type":"4"}},{"id":1042562,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T20:05:06.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":3225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":3225,"derivative":{"exercise_price":15.36,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":3225},"source":{"system":"sec-edgar","filing":"0001193125-25-201315","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000119312525201315/ownership.xml","form_type":"4"}},{"id":1042601,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T20:05:04.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":3225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":3225,"derivative":{"exercise_price":15.36,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":3225},"source":{"system":"sec-edgar","filing":"0001193125-25-201314","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000119312525201314/ownership.xml","form_type":"4"}},{"id":1042487,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T20:05:03.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":3225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":3225,"derivative":{"exercise_price":15.36,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":3225},"source":{"system":"sec-edgar","filing":"0001193125-25-201313","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312525201313/ownership.xml","form_type":"4"}},{"id":1043064,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T16:05:14.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":3225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":3225,"derivative":{"exercise_price":15.36,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":3225},"source":{"system":"sec-edgar","filing":"0001193125-25-201318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000119312525201318/ownership.xml","form_type":"4"}},{"id":1049370,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T21:33:40.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":1011,"price":13.86,"value":14012.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":18971,"source":{"system":"sec-edgar","filing":"0001193125-25-195095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000119312525195095/ownership.xml","form_type":"4"}},{"id":1049046,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T21:29:28.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":1281,"price":13.86,"value":17754.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":20805,"source":{"system":"sec-edgar","filing":"0001193125-25-195090","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000119312525195090/ownership.xml","form_type":"4"}},{"id":1049290,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T21:28:57.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":1290,"price":13.86,"value":17879.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":48441,"source":{"system":"sec-edgar","filing":"0000950170-25-112884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000095017025112884/ownership.xml","form_type":"4"}},{"id":1049923,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T21:26:43.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":1173,"price":13.86,"value":16257.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":18649,"source":{"system":"sec-edgar","filing":"0000950170-25-112882","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000095017025112882/ownership.xml","form_type":"4"}},{"id":1050158,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T17:30:44.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":975,"price":13.86,"value":13513.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":17908,"source":{"system":"sec-edgar","filing":"0001193125-25-195091","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000119312525195091/ownership.xml","form_type":"4"}},{"id":1122492,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:05:16.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":2494,"price":7.17,"value":17881.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":47151,"source":{"system":"sec-edgar","filing":"0000950170-25-081610","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000095017025081610/ownership.xml","form_type":"4"}},{"id":1123107,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:05:13.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":2267,"price":7.17,"value":16254.39,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":17476,"source":{"system":"sec-edgar","filing":"0000950170-25-081612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000095017025081612/ownership.xml","form_type":"4"}},{"id":1122612,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:05:10.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":1953,"price":7.17,"value":14003.01,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":17960,"source":{"system":"sec-edgar","filing":"0000950170-25-081611","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000095017025081611/ownership.xml","form_type":"4"}},{"id":1122288,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:05:08.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":2476,"price":7.17,"value":17752.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":19524,"source":{"system":"sec-edgar","filing":"0000950170-25-081608","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000095017025081608/ownership.xml","form_type":"4"}},{"id":1123259,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T16:05:13.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":1883,"price":7.17,"value":13501.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":4647,"source":{"system":"sec-edgar","filing":"0000950170-25-081609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000095017025081609/ownership.xml","form_type":"4"}},{"id":1222824,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T21:05:14.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":1849,"price":8.79,"value":16252.71,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":15209,"source":{"system":"sec-edgar","filing":"0000950170-25-033528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000095017025033528/ownership.xml","form_type":"4"}},{"id":1221982,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T21:05:11.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":1593,"price":8.79,"value":14002.47,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":16007,"source":{"system":"sec-edgar","filing":"0000950170-25-033525","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000095017025033525/ownership.xml","form_type":"4"}},{"id":1221294,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T21:05:05.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":2019,"price":8.79,"value":17747.01,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":17048,"source":{"system":"sec-edgar","filing":"0000950170-25-033523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000095017025033523/ownership.xml","form_type":"4"}},{"id":1221820,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T21:05:03.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":2033,"price":8.79,"value":17870.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":44657,"source":{"system":"sec-edgar","filing":"0000950170-25-033522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000095017025033522/ownership.xml","form_type":"4"}},{"id":1223234,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T16:05:15.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":1536,"price":8.79,"value":13501.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":2764,"source":{"system":"sec-edgar","filing":"0000950170-25-033540","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000095017025033540/ownership.xml","form_type":"4"}},{"id":1339317,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-12-09T16:10:04.000Z","date":"2024-10-30","kind":"grant","planned":false,"acquired":true,"shares":41745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options were awarded in accordance with the MiNK Therapeutics Inc. 2021 Amended and Restated Equity Incentive Plan on October 30, 2024 and will vest in three equal annual installments on each of October 30, 2025, 2026 and 2027 (provided Dr. Kadlec maintains a service relationship with the company through each such vesting date)."}],"balance_after":41745,"derivative":{"exercise_price":0.72,"expiration_date":"2034-10-30","underlying":"Common Stock","underlying_shares":41745},"source":{"system":"sec-edgar","filing":"0000950170-24-134524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000095017024134524/ownership.xml","form_type":"4"}},{"id":1339316,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-09T16:10:04.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":12286,"price":0.73,"value":8968.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Kadlec was granted restricted stock unites (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU.  The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":12286,"source":{"system":"sec-edgar","filing":"0000950170-24-134524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000095017024134524/ownership.xml","form_type":"4"}},{"id":1344195,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T15:44:42.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":24229,"price":0.73,"value":17687.17,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":150336,"source":{"system":"sec-edgar","filing":"0000950170-24-132525","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000095017024132525/ownership.xml","form_type":"4"}},{"id":1344563,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T15:44:13.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":24400,"price":0.73,"value":17812.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":426283,"source":{"system":"sec-edgar","filing":"0000950170-24-132524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000095017024132524/ownership.xml","form_type":"4"}},{"id":1345267,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T15:38:20.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":20987,"price":0.73,"value":15320.51,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":133634,"source":{"system":"sec-edgar","filing":"0000950170-24-132520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000095017024132520/ownership.xml","form_type":"4"}},{"id":1344653,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T15:35:43.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":20476,"price":0.73,"value":14947.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":144181,"source":{"system":"sec-edgar","filing":"0000950170-24-132518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000095017024132518/ownership.xml","form_type":"4"}},{"id":1413419,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T12:23:52.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":21649,"price":0.82,"value":17752.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date."}],"balance_after":126107,"source":{"system":"sec-edgar","filing":"0000950170-24-103750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000095017024103750/ownership.xml","form_type":"4"}},{"id":1414093,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T12:23:11.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":18753,"price":0.82,"value":15377.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date."}],"balance_after":109234,"source":{"system":"sec-edgar","filing":"0000950170-24-103749","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000095017024103749/ownership.xml","form_type":"4"}},{"id":1413646,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T12:22:01.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":18295,"price":0.82,"value":15001.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date."}],"balance_after":123705,"source":{"system":"sec-edgar","filing":"0000950170-24-103745","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000095017024103745/ownership.xml","form_type":"4"}},{"id":1413614,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T12:18:31.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":21802,"price":0.82,"value":17877.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date."}],"balance_after":405296,"source":{"system":"sec-edgar","filing":"0000950170-24-103740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000095017024103740/ownership.xml","form_type":"4"}},{"id":1490217,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T18:27:56.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":15454,"price":0.99,"value":15299.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":90481,"source":{"system":"sec-edgar","filing":"0000950170-24-069216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000095017024069216/ownership.xml","form_type":"4"}},{"id":1489341,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T18:27:03.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":17841,"price":0.99,"value":17662.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":104458,"source":{"system":"sec-edgar","filing":"0000950170-24-069215","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000095017024069215/ownership.xml","form_type":"4"}},{"id":1489694,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T18:24:56.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":15077,"price":0.99,"value":14926.23,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":105410,"source":{"system":"sec-edgar","filing":"0000950170-24-069212","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000095017024069212/ownership.xml","form_type":"4"}},{"id":1489621,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T18:22:54.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":17967,"price":0.99,"value":17787.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":383494,"source":{"system":"sec-edgar","filing":"0000950170-24-069211","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000095017024069211/ownership.xml","form_type":"4"}},{"id":1597220,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T23:00:18.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":16185,"price":0.95,"value":15375.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":75027,"source":{"system":"sec-edgar","filing":"0000950170-24-026423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000095017024026423/ownership.xml","form_type":"4"}},{"id":1593435,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T23:00:14.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":18685,"price":0.95,"value":17750.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":86617,"source":{"system":"sec-edgar","filing":"0000950170-24-026422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000095017024026422/ownership.xml","form_type":"4"}},{"id":1594976,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T23:00:11.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":15790,"price":0.95,"value":15000.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":90333,"source":{"system":"sec-edgar","filing":"0000950170-24-026426","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000095017024026426/ownership.xml","form_type":"4"}},{"id":1594653,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T23:00:07.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":18816,"price":0.95,"value":17875.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":365527,"source":{"system":"sec-edgar","filing":"0000950170-24-026421","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000095017024026421/ownership.xml","form_type":"4"}},{"id":1675998,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-01-19T01:00:06.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":660919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"An option to purchase Common Stock was granted to Dr. Buell on January 16, 2024 for her performance in 2023, and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. Half of the options will vest on June 27, 2024 and half of the options will vest on September 27, 2024"}],"balance_after":660919,"derivative":{"exercise_price":0.87,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":660919},"source":{"system":"sec-edgar","filing":"0000950170-24-005562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000095017024005562/ownership.xml","form_type":"4"}},{"id":1675997,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-01-19T01:00:06.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"An option to purchase Common Stock was granted to Dr. Buell on January 16, 2024 and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter."}],"balance_after":500000,"derivative":{"exercise_price":0.87,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000950170-24-005562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000095017024005562/ownership.xml","form_type":"4"}},{"id":1676642,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":95084,"kind":"person","name":"van Dijk Marcus Antonius","position":1,"cik":"0001881659","reported_name":"van Dijk Marcus Antonius","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2024-01-18T20:00:08.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":171078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"An option to purchase Common Stock was granted to Dr. van Dijk on January 16, 2024 for his performance in 2023, and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. Half of the options will vest on June 27, 2024 and half of the options will vest on September 27, 2024."}],"balance_after":171078,"derivative":{"exercise_price":0.87,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":171078},"source":{"system":"sec-edgar","filing":"0000950170-24-005561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881659/000095017024005561/ownership.xml","form_type":"4"}},{"id":1676641,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":95084,"kind":"person","name":"van Dijk Marcus Antonius","position":1,"cik":"0001881659","reported_name":"van Dijk Marcus Antonius","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2024-01-18T20:00:08.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"An option to purchase Common Stock was granted to Dr. van Dijk on January 16, 2024 and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter."}],"balance_after":15000,"derivative":{"exercise_price":0.87,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-005561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881659/000095017024005561/ownership.xml","form_type":"4"}},{"id":1720879,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-05T23:11:08.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":17068,"price":1.04,"value":17750.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":67932,"source":{"system":"sec-edgar","filing":"0000950170-23-068322","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827169/000095017023068322/ownership.xml","form_type":"4"}},{"id":1721221,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":53,"kind":"person","name":"Corvese Brian","position":1,"cik":"0001393207","reported_name":"Corvese Brian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-05T23:05:11.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":17188,"price":1.04,"value":17875.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":346711,"source":{"system":"sec-edgar","filing":"0000950170-23-068313","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393207/000095017023068313/ownership.xml","form_type":"4"}},{"id":1721318,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":71,"kind":"person","name":"WIINBERG ULF","position":1,"cik":"0001187314","reported_name":"WIINBERG ULF","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-05T23:05:07.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":14424,"price":1.04,"value":15000.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":74543,"source":{"system":"sec-edgar","filing":"0000950170-23-068312","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187314/000095017023068312/ownership.xml","form_type":"4"}},{"id":1722024,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":58,"kind":"person","name":"Behner Peter","position":1,"cik":"0001851420","reported_name":"Behner Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-05T23:05:04.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":14784,"price":1.04,"value":15375.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":58842,"source":{"system":"sec-edgar","filing":"0000950170-23-068311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851420/000095017023068311/ownership.xml","form_type":"4"}},{"id":1760067,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T21:49:39.000Z","date":"2023-10-16","kind":"purchase","planned":false,"acquired":true,"shares":429,"price":1.0992,"value":471.5568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market purchases reported on this line occurred at a weighted average price of $1.0992 (range of $1.09 to $1.10)."}],"balance_after":21772863,"source":{"system":"sec-edgar","filing":"0000950170-23-053601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023053601/ownership.xml","form_type":"4"}},{"id":1760066,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T21:49:39.000Z","date":"2023-10-13","kind":"purchase","planned":false,"acquired":true,"shares":19373,"price":1.1,"value":21310.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market purchases reported on this line occurred at a price of $1.10."}],"balance_after":21772434,"source":{"system":"sec-edgar","filing":"0000950170-23-053601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023053601/ownership.xml","form_type":"4"}},{"id":1760065,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T21:49:39.000Z","date":"2023-10-12","kind":"purchase","planned":false,"acquired":true,"shares":3173,"price":1.0994,"value":3488.3962,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market purchases reported on this line occurred at a weighted average price of $1.0994 (range of $1.08 to $1.10)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":21753061,"source":{"system":"sec-edgar","filing":"0000950170-23-053601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023053601/ownership.xml","form_type":"4"}},{"id":1760460,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-14T00:18:41.000Z","date":"2023-10-11","kind":"grant","planned":false,"acquired":false,"shares":695750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On October 11, 2023, in alignment with the Company's 2021 Equity Incentive Plan, Dr. Buell received a grant of 695,750 RSUs.  This new grant serves as a replacement for the RSUs initially awarded during the Company's IPO, which Dr. Buell forfeited and returned to the Company on October 11, 2023. These newly granted RSUs will vest over a five-year period, with one-third of the restricted stock units vesting on each of the third, fourth and fifth anniversaries of the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On October 11, 2023, in alignment with the Company's 2021 Equity Incentive Plan, Dr. Buell received a grant of 695,750 RSUs.  This new grant serves as a replacement for the RSUs initially awarded during the Company's IPO, which Dr. Buell forfeited and returned to the Company on October 11, 2023. These newly granted RSUs will vest over a five-year period, with one-third of the restricted stock units vesting on each of the third, fourth and fifth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On October 11, 2023, in alignment with the Company's 2021 Equity Incentive Plan, Dr. Buell received a grant of 695,750 RSUs.  This new grant serves as a replacement for the RSUs initially awarded during the Company's IPO, which Dr. Buell forfeited and returned to the Company on October 11, 2023. These newly granted RSUs will vest over a five-year period, with one-third of the restricted stock units vesting on each of the third, fourth and fifth anniversaries of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":695750},"source":{"system":"sec-edgar","filing":"0000950170-23-053381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000095017023053381/ownership.xml","form_type":"4"}},{"id":1760459,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-14T00:18:41.000Z","date":"2023-10-11","kind":"other","planned":false,"acquired":false,"shares":695750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Dr. Jennifer Buell was awarded Restricted Stock Units (\"RSUs\") which corresponded to 695,750 shares of MiNK Therapeutics, Inc. (\"Company\") common stock (\"Common Stock\").  These RSUs, tied to the Company's Initial Public Offering (\"IPO\"), vested on September 27, 2023.  Dr. Buell previously reported on Form 4s the receipt of such shares of Common Stock (the \"RSU Shares\") and subsequent sales of shares of Common Stock to cover Federal, state and local tax withholding requirements.  However, the Company and Dr. Buell agreed that it is in the best interests of the Company and its stockholders for Dr. Buell to forfeit that award in lieu of a new award that will vest over a period of five years (see Explanation of Responses #2). Therefore Dr. Buell is returning the RSU Shares to the Company.  Dr Buell has thus made the Company whole for the forfeited award by returning 695,750 shares of Company Common Stock to the Company on October 11, 2023 for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Dr. Jennifer Buell was awarded Restricted Stock Units (\"RSUs\") which corresponded to 695,750 shares of MiNK Therapeutics, Inc. (\"Company\") common stock (\"Common Stock\").  These RSUs, tied to the Company's Initial Public Offering (\"IPO\"), vested on September 27, 2023.  Dr. Buell previously reported on Form 4s the receipt of such shares of Common Stock (the \"RSU Shares\") and subsequent sales of shares of Common Stock to cover Federal, state and local tax withholding requirements.  However, the Company and Dr. Buell agreed that it is in the best interests of the Company and its stockholders for Dr. Buell to forfeit that award in lieu of a new award that will vest over a period of five years (see Explanation of Responses #2). Therefore Dr. Buell is returning the RSU Shares to the Company.  Dr Buell has thus made the Company whole for the forfeited award by returning 695,750 shares of Company Common Stock to the Company on October 11, 2023 for no consideration."}],"balance_after":232165,"source":{"system":"sec-edgar","filing":"0000950170-23-053381","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000095017023053381/ownership.xml","form_type":"4"}},{"id":1763907,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN","position":1,"cik":"0001098972","reported_name":"AGENUS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-06T20:26:25.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"shares":15001,"price":1.0919,"value":16379.5919,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market purchases reported on this line occurred at a weighted average price of $1.0919 (range of $1.02 to $1.10)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price."}],"balance_after":21749888,"source":{"system":"sec-edgar","filing":"0000950170-23-052408","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017023052408/ownership.xml","form_type":"4"}},{"id":1766481,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-04T01:15:05.000Z","date":"2023-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":65000,"price":0.9449,"value":61418.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.875 to $1.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":927915,"source":{"system":"sec-edgar","filing":"0000950170-23-051760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000095017023051760/ownership.xml","form_type":"4"}},{"id":1766480,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-04T01:15:05.000Z","date":"2023-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":58550,"price":1.0445,"value":61155.475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.99 to $1.20. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":992915,"source":{"system":"sec-edgar","filing":"0000950170-23-051760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000095017023051760/ownership.xml","form_type":"4"}},{"id":1766479,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-04T01:15:05.000Z","date":"2023-09-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":25000,"price":1.1538,"value":28845.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.08 to $1.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1051465,"source":{"system":"sec-edgar","filing":"0000950170-23-051760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000095017023051760/ownership.xml","form_type":"4"}},{"id":1771374,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-09-29T20:30:09.000Z","date":"2023-09-27","kind":"exercise","planned":false,"acquired":false,"shares":695750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted stock unit convertible into an equivalent number of shares of our common stock, which vested as to 100% of the underlying shares on September 27, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted stock unit convertible into an equivalent number of shares of our common stock, which vested as to 100% of the underlying shares on September 27, 2023."}],"balance_after":695750,"derivative":{"underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000950170-23-050807","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000095017023050807/ownership.xml","form_type":"4"}},{"id":1771373,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":25555,"kind":"person","name":"Buell Jennifer","position":1,"cik":"0001711184","reported_name":"Buell Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-29T20:30:09.000Z","date":"2023-09-27","kind":"exercise","planned":false,"acquired":true,"shares":695750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":1076465,"source":{"system":"sec-edgar","filing":"0000950170-23-050807","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711184/000095017023050807/ownership.xml","form_type":"4"}}],"next_cursor":"2023-09-29T20:30:09.000000Z,1771373"}